Investigators pooled data from 4 trials to evaluate risk for recurrence in patients with intermediate risk non-muscle-invasive bladder cancer.

ECMC is first in Western New York to offer Aquablation therapy using the AI-powered HYDROS Robotic System to treat benign ...

Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 140.0 million in the second quarter of 2026 (Q2 2025: NOK 135.6 million), and an adjusted EBITDA of NOK 27.2 million (Q2 2025: ...

The single-arm trial met its primary end point of complete response (CR) at any time, exceeding historic and contemporary ...

He's on his feet most of the time.

Data reinforce durable responses, bladder preservation, low rate of disease progression, and favorable safety and tolerability in patients with high-risk, BCG-unresponsive non-muscle invasive bladder ...

My concern is my memory, especially my speech.

My son was diagnosed with pelvic floor dysfunction (PFD) by a urologist. He went to another doctor who never found anything ...

Access to a non-invasive test shouldn't depend on where someone lives or which local service has managed to adopt it first, ...